medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-5-24-27medsovet-1785Research ArticleНЕВРОЛОГИЯNEUROLOGYБОЛЕЗНЕННЫЙ МЫШЕЧНЫЙ СПАЗМ: ДИАГНОСТИКА И ПАТОГЕНЕТИЧЕСКАЯ ТЕРАПИЯPAINFUL MUSCLE SPASM: DIAGNOSIS AND PATHOGENETIC THERAPYВоробьеваО. В.VorobyovaO. V.

Доктор медицинских наук,  профессор

Sechenov First Moscow State Medical University of the Ministry of Health

Первый Московский государственный медицинский университет имени И.М. Сеченова МинздраваРоссияMD, ProfessorRussian Federation201730122017052427Copyright © Воробьева О.В., 20172017Воробьева О.В.Vorobyova O.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1785

В статье обсуждаются вопросы патогенеза, диагностики и лечения миофасциальной боли. Представлен анализ эффективности применения миорелаксантов у пациентов с миофасциальным болевым синдромом.

The article discusses the pathogenesis, diagnosis and treatment of myofascial pain. The analysis of the effectiveness of muscle relaxants in patients with myofascial pain syndrome is provided.

острая миалгиямиофасциальный болевой синдроммиорелаксантытолперизонacute myalgiamyofascial pain syndromemuscle relaxantsTolperisoneReferencesVan Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM; Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine, 2003 Sep 1, 28(17): 1978-92.Van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM; Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine, 2003 Sep 1, 28(17): 1978-92.Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract, 2004, 17: S23-31.Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract, 2004, 17: S23-31.Morikawa K, Oshita M, Yamazaki M, Ohara N, Mizutani F, Kato H, Ito Y, Kontani H, Koshiura R. Pharmacological studies of the new centrally acting muscle relaxant 4’-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride. Arzneimittelforschung, 1987 Mar, 37(3): 331-6.Morikawa K, Oshita M, Yamazaki M, Ohara N, Mizutani F, Kato H, Ito Y, Kontani H, Koshiura R. Pharmacological studies of the new centrally acting muscle relaxant 4’-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride. Arzneimittelforschung, 1987 Mar, 37(3): 331-6.Tekes K. Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant. Open Med Chem J, 2014, 8: 17–22.Tekes K. Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant. Open Med Chem J, 2014, 8: 17–22.Ono H, Fukuda H, Kudo Y. Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. J Pharmacobiodyn, 1984 Mar, 7(3): 171-6.Ono H, Fukuda H, Kudo Y. Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. J Pharmacobiodyn, 1984 Mar, 7(3): 171-6.Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled doubleblind trial. Pain, 1996, 67(2-3): 417-425.Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled doubleblind trial. Pain, 1996, 67(2-3): 417-425.Kohne-Volland R. RGD: 53669/G. The study performed in Germany investigating the efficacy and tolerability of tolperisone on 5130 patients suffering in painful muscle spasm, 1999.Kohne-Volland R. RGD: 53669/G. The study performed in Germany investigating the efficacy and tolerability of tolperisone on 5130 patients suffering in painful muscle spasm, 1999.

The authors declare that there are no conflicts of interest present.